BIOATLA, LLC

SAN DIEGO, CA · Biotech · Public

Conditionally Active Biologics (CAB) — engineered antibodies that activate only in the tumor microenvironment to kill cancer cells while sparing healthy tissue

Claim this profile

Follows are private to you and power your alerts

Updated · bioatla.com

Sector
Biotech
Headquarters
SAN DIEGO, CA
Latest Form D
$39M, Jul 2015
Total capital
$42.3M
Federal grants
$220K
1 award · 2016
Rank in peer group#341 of 392
Private capital raised
$42.1M
2 Form D · last Jul 2015
135 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
20
20 pending · first 2023
Rank in peer group#2 of 392

Capital timeline

201420152016FEDERAL ↑EQUITY ↓Cumulative $42.3M$220K1st Form D$3.1M2nd Form D$39M
201420152016FEDERAL ↑EQUITY ↓Cumulative $42.3M$220K1st Form D$3.1M2nd Form D$39M

Latest events

  • Federal grantHealth and Human S · Phase I · Selective inhibition of platelet GPIb-alpha binding to leukocyte Mac-1 as a novel anti-thrombotic therapeutic$220K
  • Private capital raisedForm D · SEC · 2nd filing$39M
  • Private capital raisedForm D · SEC · 1st filing$3.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 392 peers

Line = median

Biotech · Molecule

  • Federal grantsBelow median
  • Granted patents#2 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Jay M. ShortResearcherExecutive Officer, DirectorLinked by 2 patents
  • Carolyn M. ShortDirectorNamed in SEC Form D filings
  • Richard A. WaldronExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 20 granted of 40
Show all 40 patent records
  • Oncoimmune IncSimilar federal contract value in Biotech · null in contracts
  • GLOBIN SOLUTIONS INCSimilar federal contract value in Biotech · null in contracts
  • ABACUS BIOSCIENCE INCSimilar federal contract value in Biotech · null in contracts
  • TAMUROBIO INC.Similar federal contract value in Biotech · null in contracts
  • MUSTANG BIO, INC.Similar federal contract value in Biotech · null in contracts
  • UNDERDOG PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .